MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI

Latest FY: 2025 Healthcare Biotechnology
Market Price $6.76
Market Cap $997.14M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-28.3% YoY
$185.74M
3-Yr CAGR: -40.5%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↓-218.7% YoY
-$70.72M
FCF Yield: -7.09%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MRVI)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $143.1M $76.3M $24.1M $7.0M
FY 2020 $284.1M +98.5% $204.4M 0.00% $152.2M $126.8M +1,719.7%
FY 2021 $799.2M +181.3% $658.7M 0.00% $368.6M $353.7M +179.0%
FY 2022 $883.0M +10.5% $714.0M 0.00% $536.0M $518.9M +46.7%
FY 2023 $288.9M -67.3% $140.2M 0.00% $126.2M $60.7M -88.3%
FY 2024 $259.2M -10.3% $108.3M 0.00% $7.5M $-22.2M -136.6%
FY 2025 $185.7M -28.3% $34.0M 0.00% $-57.6M $-70.7M -218.7%
$

Valuation

Market Price $6.76
Market Cap $997.14M
Enterprise Value $1.07B
P/E Ratio N/A
P/B Ratio 4.70
FCF Yield -7.09%
Dividend Yield N/A
Shares Outstanding 147,506,200
%

Profitability & Margins

Gross Margin 18.30%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.24x
Revenue 3-Yr CAGR -40.53%
🛡️

Financial Health & Liquidity

Current Ratio 6.60
Cash Ratio 4.83
Debt / Equity 1.374
Debt / Assets 0.379
Cash & Equivalents $216.89M
Total Debt $291.77M
Book Value / Share $1.44
💧

Cash Flow Efficiency

Operating Cash Flow -$57.57M
Capital Expenditures (CapEx) $13.15M
Free Cash Flow -$70.72M
OCF / Revenue -31.00%
FCF / Revenue -38.08%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $1.44
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $770.58M
Total Liabilities $558.20M
Stockholders' Equity $212.38M
Current Assets $296.25M
Current Liabilities $44.92M